Keros Therapeutics, Inc.
KROS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001664710
In the last 90 days, Keros Therapeutics, Inc. insiders filed 2 open-market purchases and 4 sales; 132 institutions reported holding it in 13F filings for Q2 2026, worth $198.6M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Keros Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 106 | 1 | 104 | −1 |
| Shares | 16.4M | 2.54K | 17.4M | +936.9K (+5.7%) |
| Value | $893.0M | $138.0K | $479.7M | −$413.2M (−46.3%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Keros Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Oconnor LLC | 57,321 | $1.58M | 0.02% |
| Two Sigma Investments, LP | 55,561 | $1.53M | 0.01% |
| Qube Research & Technologies Ltd | 54,031 | $1.49M | 0.01% |
| DAFNA Capital Management LLC | 39,000 | $1.08M | 0.29% |
| Jane Street Group, LLC | 33,356 | $921.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 24,346 | $673.0K | 0.01% |
| Jump Financial, LLC | 21,978 | $607.0K | 0.03% |
| D. E. Shaw & Co., Inc. | 21,056 | $582.0K | 0.00% |
| Squarepoint Ops LLC | 17,715 | $489.0K | 0.00% |
| Trexquant Investment LP | 14,341 | $396.0K | 0.02% |
| Jefferies Group LLC | 12,500 | $345.4K | 0.01% |
| Tudor Investment Corp Et Al | 12,193 | $337.0K | 0.01% |
| Bank of Montreal | 11,613 | $336.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 10,020 | $277.0K | 0.03% |
| Quantbot Technologies LP | 6,364 | $175.0K | 0.02% |
| Point72 Hong Kong Ltd | 1,006 | $28.0K | 0.00% |
| Simplex Trading, LLC | 160 | $4.00K | 0.00% |
| Group One Trading, L.P. | 100 | $3.00K | 0.00% |
| Federated Hermes, Inc. | 74 | $2.00K | 0.00% |
| Rockefeller Capital Management L.P. | 41 | $1.00K | 0.00% |
Sold out (21)
Institutions that held Keros Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Woodline Partners LP | 257,200 | $14.0M |
| Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD | 95,644 | $5.16M |
| Integral Health Asset Management, LLC | 81,000 | $4.41M |
| Millennium Management LLC | 65,688 | $3.57M |
| Susquehanna International Group, LLP | 20,045 | $1.09M |
| Schonfeld Strategic Advisors LLC | 18,097 | $984.0K |
| Handelsbanken Fonder AB | 7,400 | $402.0K |
| Invesco Ltd. | 6,980 | $379.0K |
| Manufacturers Life Insurance Company, The | 6,565 | $357.0K |
| Voya Investment Management LLC | 6,131 | $333.0K |
| ProShare Advisors LLC | 5,349 | $291.0K |
| Price T Rowe Associates Inc | 4,505 | $245.0K |
| Jasper Ridge Partners, L.P. | 4,042 | $220.0K |
| Hyperion Capital Advisors LP | 4,042 | $220.0K |
| BIT Capital GmbH | 1,700 | $92.4K |
| Lazard Asset Management LLC | 1,237 | $67.0K |
| Nisa Investment Advisors, LLC | 860 | $47.0K |
| TCI Wealth Advisors, Inc. | 76 | $4.00K |
| Parallel Advisors, LLC | 44 | $2.00K |
| Signaturefd, LLC | 13 | $1.00K |
| CWM, LLC | 8 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held Keros Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 2,542 | $138.0K |